A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...
A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | ...
A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
MSIG Insurance, a provider of general insurance solutions in Asia and part of the MS&AD Insurance Group, has introduced ...
The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors ...